. 2023 Jul 18;95(4):1095–1100. doi: 10.1038/s41390-023-02729-5

Table 1.

Comparison between patient and control groups regarding GDF15, hepcidin, and erythroferrone.

		Control group No. = 60	Patients group No. = 61	P value
GDF15 by PCR	N (CC)	44 (73.3%)	32 (52.5%)	0.035
	HT (CG)	16 (26.7%)	27 (44.3%)
	H (GG)	0 (0.0%)	2 (3.3%)
GDF15 (ng/ml)	Median (IQR)	59 (35–98.1)	576.5 (182.6–1200.5)	<0.001
GDF15 (ng/ml)	Range	7.8–218	10.5–4842.4	<0.001
Erythroferrone (ng/ml)	Median (IQR)	159.6 (86.7–349.1)	992.4 (215–1571.4)	<0.001
Erythroferrone (ng/ml)	Range	15.2–5021	48.4–5803.8	<0.001
Hepcidin (ng/ml)	Median (IQR)	2130 (1139.2–5464)	535.7 (336.4–814.1)	<0.001
Hepcidin (ng/ml)	Range	346.7–12,164.1	99.3–13,053.9	<0.001

N CC normal (wild type), Ht CG heterozygous, H GG homozygous, GDF15 growth differentiation factor 15, PCR polymerase chain reaction, SD standard deviation, IQR interquartile range.